Hemp will play an increasingly important role as a source for cannabidiol (CBD) in the USA according to a new report from the Hemp Business Journal (HBJ). The CBD Report states the cannabidiol market category will experience an incredible compound annual growth rate of 59%. Of the $2.1 billion in...

Looking very much like an asthma puffer, the Vapen Clear appears to be the first inhaler on the market to administer pharmaceutical grade medicinal marijuana extracts. The pressurized metered dose inhaler contains 1,000 mg of medication per canister. At 10mg per dose, it works out to be 100 doses from...

Health Canada has (somewhat belatedly) published its medical cannabis market data for the quarter ending June 30 - and it appears the sector is booming. The total number of registered patients at the end of June had reached more than 75,000 - growing by more than 22,000 over the previous...

Utah Governor hopeful, Mike Weinholtz, has added motivation for seeing medical cannabis legalised in his state. Mr. Weinholtz is a strong supporter of medical cannabis, but has been unable to clarify his position while his wife Donna was facing criminal charges for possession of marijuana. Mrs. Weinholtz suffers from arthritis and...

84.3% of cannabis samples submitted to a lab in California have tested positive for pesticide residues - a "cause for concern" says the laboratory. Of significant concern to Steep Hill - the testing laboratory - was the presence of a pesticide called Myclobutanil (actually a fungicide). Usually used on almonds and...

The scare mongering regarding teen marijuana use in the wake of half of U.S. states legalising access to medical cannabis appears to have been just that. Working with data from the U.S. National Survey of Drug Use and Health between 2004 and 2013, Columbia University researchers employed multilevel logistic regression...

A report estimating the cost of cultivating and manufacturing medicinal cannabis was recently released by Australia's Office of Drug Control. The report, prepared by Deloitte Access Economics, examined costs associated with three different grow scenarios: broadacre, greenhouse and indoors. In terms of cultivation to meet Australia's projected demand*, the  cost works...

Australia's Office Of Drug Control (ODC) has released the much-anticipated (and by some, feared and maligned) regulations relating to medical cannabis. The Regulation is part of the legal framework for the licensing of cultivation and production in Australia of cannabis, and the manufacture of marijuana-derived drugs. The document also details the...

Patients in New Zealand may now find it easier to access a cheaper alternative to one of only (now) three cannabis medicines permitted for use in the country. Up until the weekend, one of the only approved products was Sativex, which costs around NZD $1,100 per prescription. New Zealand Government’s has...

Australian Medical Association (AMA) Queensland wants to see more evidence and research into cannabis oil before it is made available to patients. According to an article published on the Queensland Times, AMA Queensland president Chris Zappala says there are risks associated with marijuana. "We know, for example, that the use of...